Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Ultra-high-resolution cardiac CT with NAEOTOM Alpha before TAVI

Official title: Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha Photon Counting-detector CT Before Transcatheter Aortic Valve Implantation

Run by Semmelweis University · NCT07016477 · Data updated 2026-11-12

This study will test whether ultra-high-resolution photon-counting CT can accurately detect coronary artery disease in patients having TAVI and potentially reduce the need for invasive coronary angiography.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorSemmelweis University
Academic / other
Locations7 sites (Charleston, South Carolina and 6 other locations)
StatusRecruiting
StartedJune 1, 2024
Main results expectedMay 30, 2029
Study endsMay 30, 2030
Registry record updatedJune 11, 2025
Trial IDNCT07016477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients planned for TAVI who can undergo both CT angiography and invasive coronary angiography, have acceptable kidney function (eGFR ≥30 ml/min/1.73m2), and can provide informed consent.

Probably not a fit

Patients with severe chronic renal failure, those who are pregnant or breastfeeding, on active oncologic treatment, or those for whom TAVI or CT angiography is contraindicated are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an international, prospective multicenter registry enrolling patients scheduled for transcatheter aortic valve implantation who are also undergoing clinically indicated coronary CT and invasive coronary angiography. Participants receive ultra-high-resolution photon-counting detector (PCD) coronary CT with the NAEOTOM Alpha prior to TAVI, and imaging results are compared to invasive coronary angiography to determine feasibility and diagnostic accuracy. The registry captures clinical and demographic factors, image quality metrics, and concordance with invasive angiography across multiple centers. Key exclusions include severe renal impairment, pregnancy, active oncologic treatment, or any condition that contraindicates TAVI or CT angiography.

Why it matters

Potential benefit: If successful, this approach could give frail TAVI patients more precise noninvasive coronary imaging and reduce the need for invasive angiography.

How similar studies have gone: Conventional CT coronary angiography has shown diagnostic utility in some TAVI populations, but ultra-high-resolution photon-counting CT is relatively new and currently supported mainly by limited pilot and technical studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinically indicated TAVI
* Clinically indicated CT and invasive coronary angiography
* There are no contraindications to CT angiography.
* Understanding and signing the consent form

Exclusion Criteria:

* Pregnancy or breastfeeding
* Chronic renal failure (eGFR \<30 ml/m2)
* Active oncological treatment
* Any condition for which TAVI is contraindicated and therefore no prior radiological investigation of TAVI is indicated

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting
  • University Medical Center Mainz
    Mainz, Germany
    Recruiting
  • Semmelweis University
    Budapest, Hungary
    Recruiting
  • Albert-Ludwigs-Universität Freiburg
    Freiburg im Breisgau, Germany
    Not yet recruiting
  • Universitätsklinikum Tübingen
    Tübingen, Germany
    Not yet recruiting
  • Maastricht University
    Maastricht, Netherlands
    Not yet recruiting
Show 1 more location
  • University Hospital of Zürich
    Zurich, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.